Oral Drug Delivery Resources

  1. Improve Solubility And Spray Drying Throughput For Brick Dust Compounds

    This paper presents three approaches to address poor solubility in organic solvents for spray drying as well as case studies outlining their successful application during development.

  2. Strategies For Successful Manufacturing Of Highly Potent Oral Solids 3/10/2025

    In this discussion, industry experts explore some of the key challenges in HPAPI drug product manufacturing and highlight essential factors sponsors should consider when evaluating a CDMO partner.

  3. Solid Form Screening, Rapid Formulation Selection To Meet Tight Timelines

    A comprehensive approach to evaluating drug molecules for the selection of a lead solid form and formulation can significantly accelerate development timelines and limit risks in later development.

  4. Exploring Lipid Nanoparticles For Drug Delivery 11/11/2022

    Using lipid nanoparticles (LNP) for drug delivery is a promising area of research. Discover the benefits of LNP delivery, the different types of lipid nanoparticles, their safety for drug delivery, and more.

  5. Optimizing Highly Potent API Drug Development And Manufacturing 3/10/2025

    Through expert insights and real-world case studies, this resource provides valuable perspectives on optimizing HPAPI workflows, ensuring compliance, and leveraging process advancements.

  6. Early Solid Form Screening To Guide Drug Development

    Conducting solid form screening early can help your team select and isolate the ideal lead polymorph to ensure manufacturability and stability while avoiding costs and hiccups down the road.

  7. 5 Novel Techniques For Solubility Enhancement 2/28/2022

    Thanks to insoluble drug delivery technologies, the practice of reformulating poorly soluble drug products to improve efficacy, patient compliance and safety has now been widely adopted.

  8. Solutions For Accelerated Pharmaceutical Development

    Explore an integrated service package designed to simplify and accelerate the development pathway, even for APIs with challenging properties such as low aqueous solubility and poor bioavailability.

  9. Formulation Development Strategy For Early Phase Human Studies 1/27/2022

    Determining bioavailable formulation for animal PK, GLP toxicity, first-in-human, and first-in-patient is challenging. Drug delivery systems are usually used for poorly soluble and bioavailable compounds.

  10. Drug Formulation Development: Quick Reference Guide 7/11/2022

    This guide shares the steps involved in formulation development, considerations during formulation, and how partnering with an experienced CDMO can lead to a successful commercial product.